ITMCTR2200006867尚未招募4 期
To evaluate the efficacy and safety of Longxiang Pingchuan capsule in the treatment of bronchial asthma with chronic duration (phlegm and stasis blocking lung syndrome)
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 79（—）
- 性别
- All
入选标准
- •(1) Consistent with the diagnosis of bronchial asthma, in chronic duration, the severity of mild to moderate;
- •(2) The level of asthma control in the past month was partially controlled;
- •(3) In line with the syndrome differentiation of phlegm and blood stasis;
- •(4) Aged 18-79 (including 18 and 79), both sexes;
- •(5) Voluntarily participate in the clinical trial with informed consent and signed informed consent.
排除标准
- •(1) Severe asthma; Atypical asthma, such as cough variant asthma, chest tightness variant asthma, occult asthma; Merger of upper and lower respiratory tract infection, atelectasis, pneumonia, pulmonary tuberculosis, pulmonary fibrosis, thoracic deformity, chronic obstructive pulmonary disease, bronchiectasis, cystic fibrosis, allergic bronchial lung music bacterium disease, allergic granulomatous vasculitis special types, such as infection, restrictive pulmonary disease and other air obstructive pulmonary disease;
- •(2) Accompanied by gastrointestinal discomfort symptoms such as diarrhea, epigastric discomfort or noise;
- •(3) Complicated with serious diseases of major organs or systems such as heart, brain, liver, kidney, respiratory system and blood system;
- •(4) Liver function ALT and AST exceeded the upper limit of the normal reference value 1.5 times or Scr exceeded the upper limit of the normal reference value;
- •(5) Allergic to test drugs (including positive drugs) or their ingredients and excipients;
- •(6) Pregnant or lactating women, planning to become pregnant, patients of childbearing age who are unable or unwilling to take adequate contraceptive measures during the trial period or their spouses are unwilling to take contraceptive measures;
- •(7) Suspected or confirmed history of alcohol dependence, drug abuse or drug use;
- •(8) having intellectual or mental disorders;
- •(9) Participating in or currently participating in clinical trials of other drugs or medical devices within 3 months;
- •(10) The investigator did not consider it appropriate to participate in the clinical trial.
研究者
相似试验
尚未招募
4 期
To evaluate the efficacy and safety of Longxiang Pingchuan capsule in the treatment of cough variant asthma (phlegm-stasis syndrome) : a multicenter, randomized, double-blind simulated, positive dCough variant asthmaITMCTR2200006869Dongzhimen Hospital Beijing University of Traditional Chinese Medicine
招募中
4 期
The study to evaluate the efficacy and safety of Polynucleotide on Acne ScarsPolynucleotide, Acne scarAcne scarTCTR20230213003SW HEALTHCARE CO.,LTD27
招募中
4 期
The study to evaluate the efficacy and safety of Polynucleotide for Facial Rejuvenation in ThailandHealthyPolynucleotide, Facial RejuvenationTCTR20230213002SW HEALTHCARE CO.,LTD25
招募中
4 期
The study to evaluate the efficacy and safety of Polynucleotide for Periorbital Rejuvenation in ThailandHealthyPolynucleotide, Periorbital RejuvenationTCTR20230214003SW HEALTHCARE CO.,LTD25
已完成
4 期
The study to evaluate the efficacy and safety of linear high intensity focus ultrasound for enlarged pores in Thailand, Pilot studyHealthy human volunteersHigh intensity focused ultrasoundFaceSkinTCTR20220701006Dermatologic Surgery, Dermatology department, Siriraj hospital, Thailand30